Silicon Valley Capital Partners »

Amphastar Pharmaceuticals shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $10k 229 43.91
2023-12-31 $14k 229 61.85
2023-09-30 $11k 229 45.99
2023-06-30 $13k 229 57.47

More positions owned by Silicon Valley Capital Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Invesco S&p 500 Garp Etf Etf (SPGP)
Invesco Qqq Trust Series I Etf (QQQ)
Apple Stock (AAPL)
Vanguard Information Technology Etf Etf (VGT)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Nvidia Corporation Stock (NVDA)
Ishares S&p 500 Growth Etf Etf (IVW)
Amazon Stock (AMZN)
Vanguard Growth Etf Etf (VUG)
Vanguard Mega Cap Value Etf Etf (MGV)
Goldman Sachs Activebeta U.s. Large Cap Equity Etf Etf (GSLC)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Starbucks Corp Stock (SBUX)

View all positions for Silicon Valley Capital Partners

Top funds holding Amphastar Pharmaceuticals

Federated Investors
Vanguard Group
Neuberger Berman Group
Dimensional Fund Advisors
TD Asset Management
T. Rowe Price Associates
Boone Capital Management
Charles Schwab Investment Management
Mesirow Institutional Investment Management
Oberweis Asset Management
Nordea Investment Management Ab
Bessemer
LSV Asset Management
Bank of New York Mellon
Voloridge Investment Management

View all funds holding Amphastar Pharmaceuticals